Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
Abstract Background The optimal stage for initiating antiretroviral therapies in HIV-1 bearing patients is still a matter of debate.Methods We present computer simulations of HIV-1 infection aimed at identifying the pro et contra of immediate as compared to deferred Highly Active Antiretroviral Therapy (HAART).Results Our simulations highlight that